Is yellow fever vaccination required for travel to a certain location in a specific month?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Yellow Fever Vaccination for Travel

I cannot provide a specific recommendation without knowing your destination and travel month, as yellow fever vaccination requirements and recommendations are highly location-specific and seasonally dependent.

How to Determine If You Need Yellow Fever Vaccine

You need yellow fever vaccination if you are traveling to endemic areas in sub-Saharan Africa or tropical South America where yellow fever virus transmission occurs. 1, 2

Step 1: Check Your Specific Destination

  • High-risk African destinations include Kenya, Uganda, Tanzania, Cameroon, Democratic Republic of Congo, Côte d'Ivoire, Guinea, Sierra Leone, Senegal, and most sub-Saharan African countries 3, 4
  • High-risk South American destinations include Brazil, Peru, Colombia, and forested areas of Trinidad 1, 3
  • The vaccine is recommended for travel to any of the 45 endemic countries in Africa and Latin America 3

Step 2: Understand Country Entry Requirements vs. Medical Risk

Two separate considerations exist:

  • Mandatory entry requirements: Some countries legally require proof of yellow fever vaccination for entry, even if you're only in transit, and may quarantine you for up to 6 days or deny entry without valid documentation 1
  • Actual disease risk: The medical risk of acquiring yellow fever, which varies by specific location within countries, season, and activities 2

Step 3: Timing Requirements

The vaccine must be administered at least 10 days before travel to ensure immunity and for the International Certificate of Vaccination or Prophylaxis (ICVP) to be valid. 1, 5, 2 The average time between vaccination and travel is 43 days, but many travelers receive it too close to departure 4

Step 4: Assess Your Personal Risk Factors

Contraindications (DO NOT receive vaccine):

  • Age less than 6 months 1, 2
  • Symptomatic HIV infection or CD4+ count <200 per mm³ 6
  • Primary immunodeficiencies or thymus disorders 6, 2
  • Current immunosuppressive therapy (≥20 mg/day prednisone for ≥2 weeks, chemotherapy, TNF-α inhibitors, rituximab, alemtuzumab) 6

Precautions (use caution, weigh risks vs. benefits):

  • Age 6-8 months (postpone travel if possible) 6
  • Age ≥60 years, especially first-time vaccination (8.3 serious adverse events per 100,000 doses vs. 4.7 for all ages; 7.5 times higher risk than persons aged 19-29 years) 6
  • Pregnancy (only vaccinate if travel unavoidable to high-risk area) 6, 1
  • Breastfeeding (avoid vaccine if possible) 6, 1
  • Asymptomatic HIV with CD4+ 200-499 per mm³ 6

Critical Implementation Details

Where to Get Vaccinated

You MUST receive the vaccine at an approved Yellow Fever Vaccination Center designated by your state health department. 1, 5 Vaccines given elsewhere are not valid for international travel documentation 1

Documentation Requirements

  • The ICVP must have the provider's signature AND the official yellow fever vaccination center stamp 1, 5
  • The certificate is valid beginning 10 days after vaccination and extends for 10 years 1, 5
  • An incomplete or inaccurate ICVP can result in quarantine, denied entry, or forced revaccination at the point of entry 1

If You Cannot Receive the Vaccine

If vaccination is contraindicated, obtain a medical waiver by having your physician complete the "Medical Contraindications to Vaccination" section of the ICVP with a signed, dated letter on letterhead bearing the official yellow fever vaccination stamp. 1, 2 However, destination countries may not accept the waiver 1

Emphasize strict mosquito avoidance measures: EPA-registered insect repellents containing DEET, picaridin, IR3535, or oil of lemon eucalyptus; permethrin-impregnated clothing; and screened or air-conditioned accommodations 1, 2

Understanding the Risk-Benefit Balance

Disease Risk Without Vaccination

  • Case-fatality rate for severe yellow fever: 20-50% 1, 2
  • Estimated risk for unvaccinated travelers to West Africa: 10 deaths per 100,000 during a 2-week stay 1
  • Recent fatal cases have occurred in unvaccinated travelers to South America 1
  • An estimated 200,000 cases and 30,000 deaths occur annually worldwide 2, 3

Vaccine Safety

  • Most reactions are mild (headaches, myalgia, low-grade fever in <25% of vaccinees) 1
  • Serious adverse events are rare: yellow fever vaccine-associated viscerotropic disease (YEL-AVD) occurs at 0.09-2.5 per 1,000 doses 1
  • From 1990 to present, 31 cases and 12 deaths from YEL-AVD have been reported in travelers, compared to only 6 cases of naturally acquired yellow fever 7

However, this comparison is misleading because most travelers were vaccinated, preventing natural infection. The risk-benefit analysis strongly favors vaccination for travel to high-risk areas in Africa, where the estimated risk of wild-type yellow fever substantially exceeds vaccine-related injury 7

Common Pitfalls to Avoid

  • Insufficient lead time: Starting vaccinations too close to departure is the most common error 5 Start 4-6 weeks before travel 5
  • Incomplete documentation: Failure to secure proper validation with official stamps causes serious travel disruptions 1
  • Assuming low risk based on urban itinerary: Some countries require proof even for transit, and rural exposure risk can be high 1, 8
  • Neglecting to check current requirements: Country requirements change frequently; verify before each trip 1

References

Guideline

Yellow Fever Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Yellow Fever Prevention and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Yellow fever vaccine: an effective vaccine for travelers.

Human vaccines & immunotherapeutics, 2014

Guideline

Pre-Travel Vaccinations for Developing Countries

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prevention of yellow fever in persons traveling to the tropics.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.